Selected new reviews and commentaries, 3 January 2010

3 January 2010

Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how? Wright CF, Kroese M. Hum Genet. 2009 Nov 20.

Direct-to-consumer genetics and health policy: a worst-case scenario?
Caulfield T. Am J Bioeth. 2009;9(6-7):48-50.

Direct-to-consumer genetic testing: good, bad or benign? Caulfield T, Ries NM, Ray PN, Shuman C, Wilson B. Clin Genet. 2009 Nov 21.

Human genomics: The genome finishers. Dolgin E. Nature. 2009 Dec 17;462(7275):843-5.

How many genetic variants remain to be discovered? Pawitan Y, Seng KC, Magnusson PK. PLoS One. 2009 Dec 2;4(12):e7969.

Exome sequencing makes medical genomics a reality. Biesecker LG. Nat Genet. 2010 Jan;42(1):13-4.

Sequencing technologies - the next generation.Metzker ML. Nat Rev Genet. 2010 Jan;11(1):31-46

Carrier screening, incidence of cystic fibrosis, and difficult decisions. Liou TG, Rubenstein RC. JAMA. 2009 Dec 16;302(23):2595-6.

Enzyme therapy for Fabry's disease: registered for success? Knebelmann B, Kurschat C, Thadhani R. Lancet. 2009 Dec 12;374(9706):1950-1.

Lung function and airway diseases. Weiss ST. Nat Genet. 2010 Jan;42(1):14-6.

Acting like a prion isn't always bad. Miller G. Science. 2009 Dec 4;326(5958):1338.

Could they all be prion diseases? Miller G. Science 2009 Dec 4;326(5958):1337-9.

Genomic microarrays in mental retardation: from CNV to gene, from research to diagnosis. Vissers LE, de Vries BB, Veltman JA. J Med Genet. 2009 Nov 30.

Medicine. A reinnervating microRNA. Brown RH. Science. 2009 Dec 11;326(5959):1494-5.

Kinase mutations in human disease: interpreting genotype-phenotype relationships. Lahiry P, Torkamani A, Schork NJ, Hegele RA. Nat Rev Genet. 2010 Jan;11(1):60-74.

Getting connected in the globin interactome. Ragoczy T, Groudine M. Nat Genet. 2010 Jan;42(1):16-7.

Use of genetics in the clinical evaluation of cardiomyopathy. Judge DP. JAMA. 2009 Dec 9;302(22):2471-6.

More from us